These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1123 related items for PubMed ID: 16011533

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ.
    J Infect Dis; 2003 Sep 15; 188(6):873-82. PubMed ID: 12964119
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T, Galatowicz G, Bunce C, Calder V, Lynn WA, Lightman S.
    Clin Immunol; 2006 Nov 15; 121(2):191-7. PubMed ID: 16987710
    [Abstract] [Full Text] [Related]

  • 25. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
    Siddique MA, Hartman KE, Dragileva E, Dondero M, Gebretsadik T, Shintani A, Peiperl L, Valentine F, Kalams SA.
    J Infect Dis; 2006 Sep 01; 194(5):661-5. PubMed ID: 16897665
    [Abstract] [Full Text] [Related]

  • 26. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1677-82. PubMed ID: 17097013
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characterization of CD8+ T lymphocytes in chronic HIV-1 subtype A infection in Rwandan women.
    Jiang Y, Karita E, Castor D, Jolly PE.
    Cell Mol Biol (Noisy-le-grand); 2005 Sep 02; 51 Suppl():OL737-43. PubMed ID: 16171573
    [Abstract] [Full Text] [Related]

  • 31. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH, Loutfy MR, Boulet S, Toma E, Tsoukas CM, Bernard NF.
    Antivir Ther; 2009 Sep 02; 14(3):381-92. PubMed ID: 19474472
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 02; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

  • 34. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME, Shearer WT, Kozinetz CA, Lewis DE.
    J Allergy Clin Immunol; 2001 Aug 02; 108(2):258-64. PubMed ID: 11496243
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
    Fagard C, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Leduc D, Yerly S, Price D, Dawson SJ, Klimkait T, Perneger TV, McLean A, Clotet B, Gatell JM, Perrin L, Plana M, Phillips R, Hirschel B, Swiss HIV Cohort Study.
    Arch Intern Med; 2003 May 26; 163(10):1220-6. PubMed ID: 12767960
    [Abstract] [Full Text] [Related]

  • 39. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M.
    Nat Immunol; 2002 Nov 26; 3(11):1061-8. PubMed ID: 12368910
    [Abstract] [Full Text] [Related]

  • 40. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
    Onen NF, Overton ET, Presti R, Blair C, Powderly WG, Mondy K.
    HIV Med; 2009 Aug 26; 10(7):439-46. PubMed ID: 19459993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.